Kaiser Permanente - San Francisco ( Site 0056)

San Francisco, California 94115

0 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009) — Running, not enrolling